Directory of Stock Market Company
This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.
Search into NYSE and TSX
by quote, company name or key word
ARRY - Array Biopharma Inc
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company’s drug candidates include AMG 151, ","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"
Array Biopharma Inc News
An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL ...
24/7 Wall St. - May 18, 2012
24/7 Wall St. - May 18, 2012
Real-time Company News, Economic Reports, Analyst Calls, Upgrades, Downgrades, Initiations and Key Industry News as it happens. We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.
ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update) - TheStreet.com
Updated: Notable 52-Week Highs and Lows of the Day 05/17: (ARRY) (NTES) (PCYC ...
The Mumbai Times - May 18, 2012
Notable 52-Week Highs and Lows of the Day 05/17: (ARRY) (NTES) (PCYC) High ... - StreetInsider.com (subscription)
The Mumbai Times - May 18, 2012
The 9 analysts offering 12-month price forecasts for Clearwire Corp have a median target of 2.50, with a high estimate of 4.75 and a low estimate of 2.00.
Media General Soars On Acquisition (MEG, TWMC, GALE, ARRY, NTES) - Gaining GreenNotable 52-Week Highs and Lows of the Day 05/17: (ARRY) (NTES) (PCYC) High ... - StreetInsider.com (subscription)
Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold ...
Seeking Alpha - May 17, 2012
Seeking Alpha - May 17, 2012
New York-based Hedge Fund Baker Bros. Advisors LLC, as of the most recent SEC 13-F Q1 filing, had $3.7 billion in equity assets, almost all invested in the biotech sector, and an increase from the $3.0 billion in Q4 and $2.3 billion in Q3 of 2011.
Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials
Schaeffers Research (blog) - May 17, 2012
Schaeffers Research (blog) - May 17, 2012
by Jim Cunningham 5/17/2012 2:54 PM While Wall Street can't seem to shake its euro-zone anxiety, it's some disappointing domestic data that's amplified the bearish mood on the major market indexes this afternoon.
Array BioPharma, RCM Technologies, Other Stocks Hit 52-Week Highs Thursday
Fox Business - May 17, 2012
Fox Business - May 17, 2012
While trading on above-average volume, Array BioPharma (ARRY) climbed today, reaching and then surpassing its previous 52-week high of $3.80.
Shares of Array Biopharma Inc. (ARRY) Rising Sharply in Thursday's Session
Tech24 - May 17, 2012
Tech24 - May 17, 2012
Shares of Array Biopharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focusing on the discovery, development and commercialization of small molecule drugs, have risen sharply in today's trading.
UPDATED: ASCO abstracts reveal added appeal for key cancer drug prospects
FierceBiotech - May 17, 2012
FierceBiotech - May 17, 2012
The avalanche of ASCO abstracts last night triggered a flurry of news reports about the most notable new data on experimental therapies to be revealed ahead of next month's big meeting in Chicago.
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com - May 17, 2012
TheStreet.com - May 17, 2012
By Adam Feuerstein 05/17/12 - 06:19 AM EDT BOSTON (TheStreet) -- Investors got their first look at thousands of cancer drug research abstracts released Wednesday night by the American Society of Clinical Oncology (ASCO) in advance of its closely ...
Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual ...
MarketWatch (press release) - May 16, 2012
MarketWatch (press release) - May 16, 2012
BOULDER, Colo., May 16, 2012 (BUSINESS WIRE) -- Array BioPharma Inc. (NASDAQ:ARRY) today announced oral presentations on its two MEK inhibitors, selumetinib (AZD6244) and MEK162 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting, ...
Colorado stocks: Ascent Solar up 5%; Dow tumbles
Bizjournals.com - May 15, 2012
Bizjournals.com - May 15, 2012
Wall Street ended down again Tuesday, although some Colorado stocks managed to eke out modest gains. Ascent Solar Technologies Inc. (ASTI) had the biggest increase among all Colorado stocks at 5.36 percent.
Colorado stocks: Ampio up 10%; Dow keeps falling - Denver Business Journal NYSE Media Coverage Selection of the best articles found in your favorit medias